We’re in the midst of a rapidly evolving UK environment for the life sciences industry, with a dynamic shift in our post-Brexit regulatory framework, a hugely ambitious life sciences Sector Plan and transformational changes proposed in the Government’s recent 10 Year Health Plan.
It’s been reported that the Government will make important changes to improve the commercial environment that will bolster actions already underway in support of commercial clinical research, investing in our world-leading data assets and the NHS digital app.
I’m also looking forward to the publication of the National Cancer Plan, which will see the NHS’s commitment to improve cancer outcomes evolve further.
Check out the rest of the feature here
